These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22830987)

  • 21. Microvascular dysfunction: a direct link among BMI, waist circumference and glucose homeostasis in young overweight/obese normoglycemic women?
    Kraemer-Aguiar LG; Maranhão PA; Sicuro FL; Bouskela E
    Int J Obes (Lond); 2010 Jan; 34(1):111-7. PubMed ID: 19806157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.
    Porcellati F; Rossetti P; Busciantella NR; Marzotti S; Lucidi P; Luzio S; Owens DR; Bolli GB; Fanelli CG
    Diabetes Care; 2007 Oct; 30(10):2447-52. PubMed ID: 17623819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.
    Horvath K; Bock G; Regittnig W; Bodenlenz M; Wutte A; Plank J; Magnes C; Sinner F; Fürst-Recktenwald S; Theobald K; Pieber TR
    Diabetes Obes Metab; 2008 Jun; 10(6):484-91. PubMed ID: 17764465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.
    Boss AH; Petrucci R; Lorber D
    J Diabetes Sci Technol; 2012 Jul; 6(4):773-9. PubMed ID: 22920801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin system.
    Wise S; Chien J; Yeo K; Richardson C
    Diabet Med; 2006 May; 23(5):510-5. PubMed ID: 16681559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
    Li J; Wang Y; Han L; Sun X; Yu H; Yu Y
    Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.
    Heise T; Hermanski L; Nosek L; Feldman A; Rasmussen S; Haahr H
    Diabetes Obes Metab; 2012 Sep; 14(9):859-64. PubMed ID: 22594461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-action profile of inhaled insulin.
    Heinemann L; Traut T; Heise T
    Diabet Med; 1997 Jan; 14(1):63-72. PubMed ID: 9017356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aprotinin on insulin sensitivity in non-insulin-dependent diabetes mellitus.
    Laurenti O; Piccoli A; Bravi C; Cassone-Faldetta M; Bellini C; Leoni L; Ferri C; De Mattia G
    Diabet Med; 1996 Jul; 13(7):642-5. PubMed ID: 8840098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.
    Gagnon-Auger M; du Souich P; Baillargeon JP; Martin E; Brassard P; Ménard J; Ardilouze JL
    Diabetes Care; 2010 Dec; 33(12):2502-7. PubMed ID: 20841613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection.
    Taylor R; Home PD; Alberti KG
    Diabetes Care; 1981; 4(3):377-9. PubMed ID: 7047114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose and free insulin levels after the administration of insulin by conventional syringe or jet injector in insulin treated type 2 diabetics.
    Kerum G; Profozić V; Granić M; Skrabalo Z
    Horm Metab Res; 1987 Sep; 19(9):422-5. PubMed ID: 3319860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase.
    Morrow L; Muchmore DB; Hompesch M; Ludington EA; Vaughn DE
    Diabetes Care; 2013 Feb; 36(2):273-5. PubMed ID: 23043164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of time to onset and rate of action of insulin products: importance and new approaches.
    Jain L; Parks MH; Sahajwalla C
    J Pharm Sci; 2013 Jan; 102(1):271-9. PubMed ID: 23132625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.